Intervention
Percutaneous coronary intervention
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownCoronary Artery Stents in Heart Failure With Preserved Ejection FractionNCT07560436 · 2026-03-23
RECRUITINGRevascularization Versus Medical Treatment in Patients With Ischemic Left Ventricular DysfunctionNCT05828719 · 2023-06-16
RECRUITINGPercutaneous Coronary RevascularizatiOn VERsus Coronary-Artery Bypass Grafting for Multivessel Disease in Patients With Left Ventricular Dysfunction (PROVERB)NCT05532631 · 2023-03-16
RECRUITINGPCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEFNCT07349979 · 2026-12-30
NOT_YET_RECRUITINGComplex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting StentsNCT04475380 · 2018-09-21
COMPLETEDTroponin I and T and Adverse Outcomes in Patients With and Without Diabetes Mellitus After Coronary InterventionNCT03627455 · 2003-01-01
COMPLETEDCommon conditions
Coronary Artery Disease4Heart Failure With Reduced Ejection Fraction2Acute Coronary Syndrome1Angina Pectoris1Angina, Unstable1Coronary Restenosis1Coronary Stenosis1Diabetes Mellitus1Heart Failure1Heart Failure With Preserved Ejection Fraction (HFPEF)1Ischemic Cardiomyopathy1Myocardial Infarction1Revascularization1Stable GDMT1
Leading sponsors
Trial status mix
RECRUITING3
COMPLETED2
NOT_YET_RECRUITING1
Phase mix
NA3
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.